Form 8-K - Current report:
SEC Accession No. 0001279569-22-000674
Filing Date
2022-05-02
Accepted
2022-05-02 15:25:47
Documents
14
Period of Report
2022-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 31868
2 NEWS RELEASE DATED APRIL 26, 2022 ex991.htm EX-99.1 12147
3 GRAPHIC logo.jpg GRAPHIC 2698
  Complete submission text file 0001279569-22-000674.txt   224007

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffnt-20220502.xsd EX-101.SCH 2977
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffnt-20220502_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffnt-20220502_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3427
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 22881540
SIC: 2833 Medicinal Chemicals & Botanical Products